| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1995;25:834-838.)
© 1995 American Heart Association, Inc.
Articles |
From the Cardiovascular Center and the Departments of Anesthesia (E.A.A.) and Internal Medicine (D.A.M., A.L.M.), College of Medicine, University of Iowa, and the Veterans Administration Medical Center, Iowa City.
Correspondence to Dr Allyn L. Mark, Cardiovascular Div, Dept of Internal Medicine, University of Iowa, 200 Hawkins Dr, Iowa City, IA 52242-1081.
| Abstract |
|---|
|
|
|---|
Key Words: kidney sympathetic nervous system obesity rats, Zucker sodium, dietary
| Introduction |
|---|
|
|
|---|
In contrast to the finding of low levels of SNA to brown adipose tissue in obese Zucker rats, there is evidence that SNA to muscle in humans is directly related to percent body fat.6 7 In addition, Kassab et al8 have recently reported that renal SNA plays an important role in obesity-induced hypertension.
The goal of the current study was to compare renal SNA in obese and lean Zucker rats consuming low and high salt diets. We wanted to determine whether obese Zucker rats have low renal SNA, as might be predicted from studies of SNA to brown adipose tissue in these rats, or have high renal SNA, as might be predicted from models of acquired obesity.
| Methods |
|---|
|
|
|---|
Conscious Renal SNA Recording
At the end of the diet period, rats were anesthetized with
methohexital sodium (40 mg/kg IP; Brevital, Eli Lilly). A catheter was
inserted into a femoral artery for measurement of arterial pressure and
another catheter was introduced into a femoral vein for administration
of anesthetic and drugs. Both catheters were tunneled subcutaneously
and exited out of the nape of the neck. Anesthesia was sustained by
continuous infusion of methohexital sodium (5
mg · kg-1 · min-1 IV) while a left
retroperitoneal incision was made. From this dissection, a nerve
fascicle to the left kidney was isolated and placed on a bipolar
platinum-iridium electrode (Cooner Wire). After an optimal nerve
recording was obtained, as described previously in a report from our
laboratory,9 silicone gel (Sil-Gel 604, Wacker-Chemie) was
applied and allowed to harden before securing of the electrode to
surrounding muscle. The other end of the electrode was carefully
tunneled underneath the skin and exited through the same incision as
the femoral catheters. All incisions were closed and the rat was
allowed to recover until the next day.
After 16 to 24 hours of recovery, the femoral arterial catheter was connected to a pressure transducer (model p231D, Gould Electronics) for measurement of systolic, diastolic, and mean arterial pressures and heart rate on a thermal array recorder (TA-4000, Gould Electronics). The femoral venous catheter was connected to a PE-10 extension for later administration of drugs. The nerve electrode was attached to a high-impedance probe (HIP-511, Grass Instruments), amplified by 105, and filtered at low- and high-frequency cutoffs of 700 and 2000 Hz, respectively, with a nerve traffic analysis system (model 662-C, University of Iowa Bioengineering). The filtered, amplified nerve signal was routed (1) to an oscilloscope (model 54501A, Hewlett-Packard) for monitoring and to a DC amplifier for permanent display of the neurogram on the Gould TA-4000 recorder, (2) to a resetting spike counter that counts 100 action potentials before resetting to zero, and (3) to a resetting voltage integrator (model B600C, University of Iowa Bioengineering) that sums the total voltage output to a unit of 1 V · s before resetting to zero.
To measure renal SNA, we made recordings of the renal nerve signal while the animals were in the conscious resting state and again after ganglionic blockade with chlorisondamine (30 mg/kg IV) and after the rat was killed with methohexital sodium (150 mg/kg IV). Using tapes of the recordings, we set the upper margin of the activity after death as a cursor in analyzing the recordings in the conscious state for spike counting. Action potentials exceeding this cursor were counted. In the measurement of renal SNA as integrated voltage, all the activity in the filtered neurogram was analyzed. The integrated voltage after death was subtracted from the integrated voltage in the conscious state to calculate renal SNA (Fig 1). Although not presented in this article, similar results for renal SNA were obtained when the signal after ganglionic blockade was used as noise rather than the signal after death.
|
Experimental Protocol
Simultaneous measurements of heart rate and systolic, diastolic,
and mean arterial pressures, as well as basal renal SNA as measured by
the spike counter (spikes per second) and by the resetting integrator
(V · s · min-1), were obtained from conscious
unrestrained Zucker obese and lean rats. Recordings were continuously
displayed on the Gould TA-4000 recorder and stored for later
analysis on videotape (model 4000a, AR Vetter). These parameters
were selectively recorded during the time the rat was quiescent for up
to 20 minutes.
Renal Nerve Morphology
To determine whether there were differences in renal nerve
morphology that might explain differences in the nerve recordings, we
performed additional experiments in which a renal nerve fascicle to the
left kidney was isolated as if to perform a nerve recording. This was
done in four obese and four lean Zucker rats. The fascicle was
immersion fixed for 20 minutes with 1.0% paraformaldehyde and 1.0%
glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.6). After
sectioning, each fascicle was immersed in the same fixative for an
additional 60 minutes, then postfixed in 1.0% osmium tetroxide and
1.5% potassium ferrocyanide in 0.1 mol/L sodium cacodylate buffer for
2 hours. The fascicle was then en bloc stained for 20 minutes in 2.5%
uranyl acetate, dehydrated by graded ethanol solutions, and embedded in
Polybed 812. One-millimeter light level sections were cut from the
Polybed 812 block on an ultramicrotone (Reichert-Jung Ultracut E),
stained with Richardson's biological stain, and digitized under the
light microscope (x100) for cross-sectional dimensions.
Data Analysis
Statistical comparisons of baseline values of systolic,
diastolic, and mean arterial pressures and renal SNA were performed to
compare data from the Zucker obese rats with those from the lean rats
fed one of the two diets using an unpaired t test and by
ANOVA with the Bonferroni method for multiple comparison.
P<.05 was considered significant. Results are expressed as
mean±SEM.
| Results |
|---|
|
|
|---|
|
To determine whether the differences in arterial pressure would be greater with longer duration of the high salt diet, we measured arterial pressure in separate groups of obese rats fed the low salt or the high salt diet for 4 weeks. Mean arterial pressure in eight obese rats fed the high salt diet was significantly, albeit modestly, higher (120±4 mm Hg) than in eight obese rats fed the low salt diet (110±2 mm Hg, P<.05).
Heart rates did not differ in the four groups except for a slightly but significantly (P<.05) lower heart rate in obese rats fed the high salt diet (Table).
Renal SNA
Fig 2 shows the filtered renal neurograms and the
output from the spike counter and voltage integrator during the
conscious state and at 30 minutes after death from a lean and an obese
rat fed the low salt diet. Fig 3 shows the filtered
neurograms from obese and lean rats fed either the low salt or the high
salt diet. Summary data are presented in Fig 4.
Renal SNA calculated as either spikes per second or integrated voltage
was higher in obese rats than in lean rats on either diet. In lean
rats, renal SNA was similar during the low salt and the high salt diet.
In obese rats, renal SNA calculated as spikes per second did not differ
during the low salt and the high salt diet, but renal SNA calculated as
integrated voltage was greater (P<.05) during the high salt
diet.
|
|
|
Renal Morphology
There were no qualitative differences in the morphology of
renal nerve fascicles from obese and lean rats. Cross-sectional area
tended to be lower in obese rats, but there was substantial overlap in
the two groups (Fig 5).
|
| Discussion |
|---|
|
|
|---|
The discussion will focus on several issues: (1) the validity of the measurement of renal SNA, (2) potential mechanisms for higher renal SNA, and (3) regulation of arterial pressure.
Methodology
The results of this study depend on the validity of a comparison
of multifiber recordings of SNA between groups of animals. Some
investigators have suggested that variables involved in the
technique limit the validity of measurements of basal SNA from
multifiber recordings. In contrast, there have been a number of reports
by various investigators comparing basal SNA between
animals.10 11 12
Our view was that there is no a priori reason why multifiber recordings of renal SNA could not be used for comparison of basal SNA between animals if the techniques were standardized and if there were no major differences in renal nerve morphology that would introduce systematic bias in the measurements in the two groups. The techniques used in our study were highly standardized from animal to animal. Filter settings and amplification were standardized, as were the methods of analyzing the recordings. There were also no qualitative or systematic differences in renal nerve fascicle morphology that would explain differences in the nerve recordings. It might be argued that the apparent differences in renal SNA reflect differences in afferent rather than efferent activity, but this seems unlikely because eliminating renal SNA with ganglionic blockade (not death) also revealed higher SNA in obese animals than in lean animals. We conclude that the higher values for renal SNA in the obese rats reflect a higher level of SNA and not an artifact of the method.
Potential Mechanisms for Higher Renal SNA
In a broad sense, there are three potential mechanisms for higher
renal SNA in the obese rats. First, the elevated renal SNA could be a
direct result of the genetic mutation responsible for obesity in the
Zucker rats. As mentioned above, it is thought that the fatty mutation
in the Zucker rats results in a lower level of SNA to brown adipose
tissue that in turn promotes decreased thermogenesis and thereby
obesity. It has been known that the altered SNA in obese Zucker rats is
tissue specific.2 It is possible that the higher renal SNA
is also a result of the fatty mutation (independent of the obesity).
Second, the elevated SNA could be secondary to increased body weight or
fat and not a direct result of the genetic mutation that causes obesity
in the Zucker rats. There have been reports that muscle SNA is directly
related to percent body fat in humans.6 The precise
mechanisms linking increased body fat and SNA in either humans or
animals are not known. Insulin resistance and hyperinsulinemia promote
sympathetic activation,13 and obese Zucker rats are
insulin resistant and hyperinsulinemic.14 15 However, it
is not known whether the higher renal SNA reflects hyperinsulinemia or
other possible effects of obesity. Studies in young genetically obese
Zucker rats before the development of obesity would help to determine
whether the elevated renal SNA is a direct result of the genetic
differences between the obese and lean Zucker rats or the result of
increased body fat. Third, the higher renal SNA in the obese rats might
reflect genetic differences between the obese and lean rats that are
unrelated to the fatty mutation or obesity, ie, that are due to genetic
drift.
Regulation of Arterial Pressure
Obese Zucker rats have been reported by some investigators to have
higher arterial pressure than the lean rats16 17 and to
develop higher arterial pressure during a high salt
diet.18 In contrast, other investigators have failed to
find a difference in arterial pressure between obese and lean Zucker
rats.19 20 In addition, even in those studies in which
arterial pressure was higher in obese than in lean Zucker rats, the
elevation in arterial pressure was not impressive. We did not observe a
difference in arterial pressure between the obese and lean rats during
the low salt diet. During the high salt diet, mean arterial pressure
was significantly higher in the obese rats than in the lean rats, but
the difference was not striking.
The reasons for the lack of significant or striking hypertension in the obese rats are not clear and are beyond the scope of this study. We would note, however, that the rats in our study were obese and thus had the phenotypic expression of the fatty mutation. We therefore speculate in a broad way that either the fatty mutation does not contribute importantly to hypertension even during the high salt diet or, alternatively, that the genetic background of the obese Zucker rat modulates a hypertensive effect of the fatty mutation and obesity.
Relationship of Renal SNA and Arterial Pressure
The renal nerves have been reported to contribute to sodium
retention and hypertension in obesity.8 21 In addition,
exaggerated stress-induced increases in renal SNA have been shown to
contribute to exaggerated sodium and water reabsorption in Okamoto
spontaneously hypertensive rats, particularly during a high salt
diet.22 23 There are several possible interpretations for
our finding of higher basal renal SNA in the absence of significant
elevation of arterial pressure. First, the elevated levels of SNA may
not have reached the threshold for a significant pathophysiological
effect. Second, basal levels may be less important than stress-induced
levels of SNA. Third, high levels of renal SNA may contribute to
elevated arterial pressure but may not be a sufficient factor in
the absence of other prohypertensive influences.
This study indicates that obese Zucker rats have higher levels of basal renal SNA than do lean Zucker rats.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2.
Levin BE, Triscari J, Sullivan A. Studies of origins of
abnormal sympathetic function in obese Zucker rats. Am J
Physiol. 1983;245:E87-E93.
3. Holt SJ, York DA. Studies on the sympathetic efferent nerves of brown adipose tissue of lean and obese Zucker rats. Brain Res. 1989;481:106-112. [Medline] [Order article via Infotrieve]
4. Krief S, Bazin R, Dupuy F, Lavau M. Role of brown adipose tissue in glucose utilization in conscious pre-obese Zucker rats. Biochem J. 1989;263:305-308. [Medline] [Order article via Infotrieve]
5. Krief S, Bazin R. Genetic obesity: is the defect in the sympathetic nervous system? A review through developmental studies in the preobese Zucker rat. Proc Soc Exp Biol Med. 1991;198:528-538. [Medline] [Order article via Infotrieve]
6.
Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier
E, Nicod P. Body fat and sympathetic nerve activity in healthy
subjects. Circulation. 1994;89:2634-2640.
7. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity: a potential mechanism predisposing to body weight gain. J Clin Invest. 1993;92:1730-1735.
8. Kassab SE, Kato T, Wilkins C, Chen R, Hall JE, Granger JP. Bilateral renal denervation prevents the development of obesity-induced hypertension in dogs. Hypertension. 1994;24:375. Abstract.
9.
Morgan DA, Balon TW, Ginsberg BH, Mark AL. Nonuniform
regional sympathetic nerve responses to hyperinsulinemia in rats.
Am J Physiol. 1993;264:R423-R427.
10.
Judy WV, Watanabe AM, Murphy WR, Aprison BS, Pao-Lo Y.
Sympathetic nerve activity and blood pressure in normotensive backcross
rats genetically related to the spontaneously hypertensive rat.
Hypertension. 1979;1:598-604.
11. Lundin S, Ricksten S-E, Thorén P. Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Acta Physiol Scand. 1984;120:265-272. [Medline] [Order article via Infotrieve]
12.
Negrão CE, Irigoyen MC, Moreira ED, Brun PC, Freire PM,
Krieger EM. Effect of exercise training on RSNA, baroreflex
control, and blood pressure responsiveness. Am J Physiol. 1993;265:R365-R370.
13.
Anderson EA, Mark AL. The vasodilator action of insulin:
implications for the insulin hypothesis of hypertension.
Hypertension. 1993;21:136-141.
14. Bray G. The Zucker-fatty rat: a review. Fed Proc. 1977;36:148-153. [Medline] [Order article via Infotrieve]
15. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension. 1992;19(suppl I):I-110-I-115.
16.
Kurtz TW, Morris C, Pershadsingh HA. The Zucker fatty rat as a
genetic model of obesity and hypertension.
Hypertension. 1989;13:896-901.
17.
Zemel MB, Peuler JD, Sowers JR, Simpson L. Hypertension in
insulin-resistant Zucker obese rats is independent of sympathetic
neural support. Am J Physiol. 1992;262:E368-E371.
18.
Reddy SR, Kotchen TA. Dietary sodium chloride increases blood
pressure in obese Zucker rats. Hypertension. 1992;20:389-393.
19. Pawloski CM, Kanagy NL, Mortensen LH, Fink GD. Obese Zucker rats are normotensive on normal and increased sodium intake. Hypertension. 1992;19(suppl I):I-90-I-95.
20. Buñag RD, Barringer DL. Obese Zucker rats, through still normotensive, already have impaired chronotropic baroreflexes. Clin Exp Hypertens A. 1988;10:257-262.
21. Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger J. Renal nerves play an important role in mediating the sodium retention in response to a high-fat diet in conscious dogs. Am J Hypertens. 1994;7:26A. Abstract.
22. DiBona GF. The function of the renal nerves. Rev Physiol Biochem Pharmacol. 1982;94:76-81.
23.
Koepke JP, DiBona GF. High sodium intake enhances renal nerve
and antinatriuretic responses to stress in spontaneously hypertensive
rats. Hypertension. 1985;7:357-363.
This article has been cited by other articles:
![]() |
A. Nagae, M. Fujita, H. Kawarazaki, H. Matsui, K. Ando, and T. Fujita Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Obesity-Induced Hypertension Circulation, February 24, 2009; 119(7): 978 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Kopp, M. Z. Cicha, and M. A. Yorek Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R858 - R866. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schindler Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 7 - 26. [Abstract] [PDF] |
||||
![]() |
D. W. Stepp, E. I. Boesen, J. C. Sullivan, J. D. Mintz, C. D. Hair, and D. M. Pollock Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2537 - H2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Schreihofer, D. A. Mandel, S. C. Mobley, and D. W. Stepp Impairment of sympathetic baroreceptor reflexes in obese Zucker rats Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2543 - H2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruggeri, A. Brunori, C. E. Cogo, D. Storace, F. Di Nardo, and R. Burattini Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R376 - R382. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Frisbee Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome J Appl Physiol, February 1, 2006; 100(2): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Schreihofer, C. D. Hair, and D. W. Stepp Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R253 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Banday, T. Hussain, and M. F. Lokhandwala Renal dopamine D1 receptor dysfunction is acquired and not inherited in obese Zucker rats Am J Physiol Renal Physiol, July 1, 2004; 287(1): F109 - F116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sharma Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension? Hypertension, July 1, 2004; 44(1): 12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Weiss and S. Shore Obesity and Asthma: Directions for Research Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 963 - 968. [Full Text] [PDF] |
||||
![]() |
O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Malpas What sets the long-term level of sympathetic nerve activity: is there a role for arterial baroreceptors? Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R1 - R12. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin J. Neurosci., July 9, 2003; 23(14): 5998 - 6004. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vaskonen, E. Mervaala, L. Krogerus, and H. Karppanen Supplementation of Plant Sterols and Minerals Benefits Obese Zucker Rats Fed an Atherogenic Diet J. Nutr., February 1, 2002; 132(2): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Malpas Neural influences on cardiovascular variability: possibilities and pitfalls Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H6 - H20. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paolisso, D. Manzella, M. R. Rizzo, E. Ragno, M. Barbieri, G. Varricchio, and M. Varricchio Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects Am. J. Clinical Nutrition, September 1, 2000; 72(3): 723 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Oskarsson, L. Coppey, R. M. Weiss, and W.-G. Li Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction Cardiovasc Res, February 1, 2000; 45(3): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Carlson, J. Shelton, C. R. White, and J. M. Wyss Elevated Sympathetic Activity Contributes to Hypertension and Salt Sensitivity in Diabetic Obese Zucker Rats Hypertension, January 1, 2000; 35(1): 403 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Sivitz, B. D. Fink, D. A. Morgan, J. M. Fox, P. A. Donohoue, and W. G. Haynes Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E668 - E677. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |